|
PTPN11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.320600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.990400E-01 |
| Normal-vs-Stage2 |
9.537400E-01 |
| Normal-vs-Stage3 |
6.127800E-01 |
| Normal-vs-Stage4 |
9.559800E-01 |
| Stage1-vs-Stage2 |
6.571200E-01 |
| Stage1-vs-Stage3 |
3.678200E-01 |
| Stage1-vs-Stage4 |
7.242000E-01 |
| Stage2-vs-Stage3 |
7.702600E-01 |
| Stage2-vs-Stage4 |
9.811200E-01 |
| Stage3-vs-Stage4 |
8.515000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.160200E-01 |
| Normal-vs-AfricanAmerican |
3.290200E-01 |
| Normal-vs-Asian |
4.854200E-01 |
| Caucasian-vs-AfricanAmerican |
1.488990E-01 |
| Caucasian-vs-Asian |
6.904600E-01 |
| AfricanAmerican-vs-Asian |
4.124800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.981600E-01 |
| Normal-vs-Female |
8.559500E-02 |
| Male-vs-Female |
1.008040E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.734200E-01 |
| Normal-vs-Extreme_Weight |
7.496700E-03 |
| Normal-vs-Obese |
1.823980E-01 |
| Normal-vs-Extreme_Obese |
3.238000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.733770E-01 |
| Normal_Weight-vs-Obese |
1.917200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.003200E-01 |
| Extreme_Weight-vs-Obese |
1.401060E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.500800E-01 |
| Obese-vs-Extreme_Obese |
1.769210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.727790E-01 |
| Normal-vs-Age(41-60Yrs) |
3.921600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.355200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.388400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.824000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.841800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.000100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.248100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.205400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.650400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.720800E-01 |
| Normal-VS-Type2 PRCC |
4.360600E-01 |
| Normal-VS-KIRP CIMP |
3.115800E-01 |
| Normal-VS-Unclassified PRCC |
1.153620E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.413000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.938770E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.267900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.690800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.085600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.937800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.794400E-02 |
| Normal-vs-N1 |
1.227230E-01 |
| Normal-vs-N2 |
7.913000E-01 |
| N0-vs-N1 |
5.357200E-03 |
| N0-vs-N2 |
4.276200E-01 |
| N1-vs-N2 |
5.728000E-01 |
|
|
